Data as of Q4 2025 (Dec 31, 2025)
SPRY

ARS PHARMACEUTICALS INC

Institutional Ownership ยท Q4 2025

Filing: Q4 2025

ARS PHARMACEUTICALS INC (SPRY) is held by 182 institutional investors with combined holdings of $993M. Major holders include RA CAPITAL MANAGEMENT, L., ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT COMP.

Institutional Holders
182
Total Value
$993.0M
Ownership %
85.8%